Figure 5
From: The changes of Th17 cells and the related cytokines in the progression of human colorectal cancers
Percentages of Th17 cell in the stimulated PBMCs in the presence of different cytokines. Percentages of Th17 cells over the anti-CD3/CD28-stimulated PBMCs of the healthy donors following treatment with IL-1βhi (25 ng/ml), IL-1βlo (10 ng/ml), IL-6hi (50 ng/ml), IL-6lo (25 ng/ml), TGF-βhi (5 ng/ml) and TGF-βlo (0.5 ng/ml) are indicated. Results are expressed as mean ± SEM from six independent experiments. * P < 0.05, ** P < 0.01.